VENTYX BIOSCIENCES INC (VTYX)
US92332V1070 - Common Stock
ChartMill assigns a Buy % Consensus number of 79% to VTYX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.02. This target is 180.31% above the current price.
VTYX was analyzed by 16 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about VTYX.
In the previous month the buy percentage consensus was at a similar level.
VTYX was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-03-12 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2024-03-12 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2024-03-11 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-02-21 | Oppenheimer | Reiterate | Perform |
| 2023-12-19 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2023-12-18 | Stifel | Maintains | Hold -> Hold |
| 2023-11-10 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2023-11-07 | Stifel | Downgrade | Buy -> Hold |
| 2023-11-07 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2023-11-07 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-10-10 | Stifel | Reiterate | Buy -> Buy |
| 2023-10-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-29 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-08-11 | Credit Suisse | Maintains | Outperform -> Outperform |
| 2023-08-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-07-05 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-07-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-24 | Oppenheimer | Maintains | Outperform |
| 2023-03-24 | Credit Suisse | Reiterate | Outperform |
| 2023-03-21 | Wells Fargo | Initiate | Overweight |
| 2023-03-20 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-31 | Canaccord Genuity | Maintains | Buy |
| 2023-01-27 | Oppenheimer | Maintains | Outperform |
| 2022-12-19 | Goldman Sachs | Initiate | Buy |
| 2022-11-17 | Morgan Stanley | Initiate | Overweight |
| 2022-09-16 | Stifel | Maintains | Buy |
| 2022-09-13 | HC Wainwright & Co. | Maintains | Buy |
| 2022-09-12 | Oppenheimer | Maintains | Outperform |